This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
NMDA receptor: Difference between revisions
Jump to navigation
Jump to search
>Kaylee Created page with "==Structure== ==Function== ==The Role of NMDA Receptors in Excitotoxicity== ==Drugs which act on the NMDA receptor==" |
>Blackhole put headerpanel back into header :) |
||
| (5 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
{{headerpanel|{{stub}}}} | |||
The '''N-methyl-D-aspartate receptor''' ('''NMDA receptor''' or '''NMDAR''') is a type of [[glutamate]] (main excitatory [[neurotransmitter]]) receptor in the brain. | |||
==Structure== | ==Structure== | ||
==Function== | ==Function== | ||
== | ==Role of NMDA receptors in excitotoxicity== | ||
==Drugs which act on the NMDA receptor== | ==Drugs which act on the NMDA receptor== | ||
<div class="flex-panel"> | |||
<div class="flex-column"> | |||
<div class="panel radius"> | |||
<h3 class="panel-header">[[Dissociatives]]</h3> | |||
<ul class="featured-table"> | |||
<li class="featured list-item"> | |||
*[[2-Fluorodeschloroketamine]] (''2-FDCK'') | |||
*[[3-MeO-PCMo]] | |||
*[[3-MeO-PCP]] | |||
*[[3-MeO-PCE]] | |||
*[[4-MeO-PCP]] | |||
*[[DCK]] | |||
*[[Ketamine]] | |||
*[[Methoxetamine]] (''MXE'') | |||
*[[Methoxyketamine]] | |||
*[[O-PCE]] | |||
*[[Phencyclidine]] (''PCP'') | |||
*[[Dextromethorphan]] (''DXM'') | |||
*[[Dextrorphan]] (''DXO'') | |||
*[[Diphenidine]] | |||
*[[Methoxphenidine]] (''MXP'') | |||
*[[Ephenidine]] | |||
*[[Myristicin]] | |||
*[[Nitrous oxide]] | |||
*[[Xenon]] | |||
*[[Memantine]] | |||
</li> | |||
</ul> | |||
</div> | |||
</div> | |||
<div class="flex-column"> | |||
<div class="panel radius"> | |||
<h3 class="panel-header">Partial Antagonists and Modulators</h3> | |||
<ul class="featured-table"> | |||
<li class="featured list-item"> | |||
*[[Ethanol]] | |||
*[[Ibogaine]] | |||
*[[Methadone]] | |||
*[[Tramadol]] | |||
*[[L-theanine]] | |||
*[[Tianeptine]] | |||
</li> | |||
</ul> | |||
</div> | |||
</div> | |||
</div> | |||
==External links== | |||
*[https://en.wikipedia.org/wiki/NMDA_receptor NMDA receptor (Wikipedia)] | |||
==References== | |||
{{references}} | |||
[[Category:Pharmacology]] | |||
Latest revision as of 04:54, 2 June 2024
 |
This article is a stub. As such, it may contain incomplete or wrong information. You can help by expanding it. |
The N-methyl-D-aspartate receptor (NMDA receptor or NMDAR) is a type of glutamate (main excitatory neurotransmitter) receptor in the brain.
Structure
Function
Role of NMDA receptors in excitotoxicity
Drugs which act on the NMDA receptor
Dissociatives
-
- 2-Fluorodeschloroketamine (2-FDCK)
- 3-MeO-PCMo
- 3-MeO-PCP
- 3-MeO-PCE
- 4-MeO-PCP
- DCK
- Ketamine
- Methoxetamine (MXE)
- Methoxyketamine
- O-PCE
- Phencyclidine (PCP)
- Dextromethorphan (DXM)
- Dextrorphan (DXO)
- Diphenidine
- Methoxphenidine (MXP)
- Ephenidine
- Myristicin
- Nitrous oxide
- Xenon
- Memantine
Partial Antagonists and Modulators
External links
References
 |
This article does not cite enough references. You can help by adding some. |